...
首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
【24h】

Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.

机译:比色氧化还原指示剂方法用于结核分枝杆菌中多药耐药性的快速检测:系统综述和荟萃分析。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: With the spread of multidrug-resistant tuberculosis (MDR-TB) there is increasing demand for new accurate and cost-effective tools for rapid drug susceptibility testing (DST), particularly for developing countries. The reference standard method used today for DST is very slow and cumbersome. Colorimetric assays using redox indicators have been proposed to be used in low-resource countries as rapid alternative culture methods for the detection of resistance especially to rifampicin and isoniazid. These methods appear as promising new tools but their accuracy has not been systematically evaluated. METHODS: We did a meta-analysis to evaluate the accuracy of the colorimetric assays for the detection of rifampicin and isoniazid-resistant tuberculosis among clinical isolates. We searched Medline, PubMed (NCBI), Global health-CAB, EJS-E (EbscoHost), ISI Web, Web of Science and IFCC databases and contacted authors if additional information was needed. RESULTS: Eighteen studies met our inclusion criteria for rifampicin resistance detection and 16 for isoniazid. We used a summary receiver operating characteristic (SROC) curve to perform meta-analysis and summarize diagnostic accuracy. For both drugs, all studies had a sensitivity and specificity that ranged between 89% and 100%. CONCLUSIONS: There is evidence that colorimetric methods are highly sensitive and specific for the rapid detection of MDR-TB. These new tools could offer affordable technologies for TB laboratories especially in places where resources are limited and where the prevalence of MDR-TB is important and make TB control efforts more effective. Additional studies are needed in high MDR prevalence countries and cost-effectiveness analysis to have more evidence on the utility of these methods. Future developments to detect resistance directly from smear-positive sputum specimens should be taken into consideration to speed up the process.
机译:目的:随着耐多药结核病(MDR-TB)的扩散,对快速准确的药敏试验(DST)的新的精确且具成本效益的工具的需求不断增加,特别是对于发展中国家。今天用于DST的参考标准方法非常缓慢且麻烦。已提出在低资源国家中使用氧化还原指示剂进行比色测定,作为快速替代培养方法来检测耐药性,尤其是对利福平和异烟肼的耐药性。这些方法似乎是很有前途的新工具,但其准确性尚未得到系统的评估。方法:我们进行了荟萃分析,以评估比色法检测临床分离株中利福平和耐异烟肼的结核病的准确性。我们搜索了Medline,PubMed(NCBI),全球卫生CAB,EJS-E(EbscoHost),ISI Web,Web of Science和IFCC数据库,并在需要其他信息时与作者联系。结果:18项研究符合我们对利福平耐药性检测的入选标准,16项符合异烟肼的入选标准。我们使用摘要接收器工作特性(SROC)曲线进行荟萃分析并总结诊断准确性。对于这两种药物,所有研究的敏感性和特异性都在89%至100%之间。结论:有证据表明,比色法对MDR-TB的快速检测具有高度的敏感性和特异性。这些新工具可以为结核病实验室提供负担得起的技术,尤其是在资源有限且耐多药结核病的流行很重要的地方,并使结核病控制工作更加有效。在耐多药流行率较高的国家和成本效益分析中,还需要进行更多的研究,以更多地了解这些方法的实用性。应考虑将来直接从涂片阳性痰标本中检测耐药性的进展,以加快这一过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号